SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-084736
Filing Date
2024-04-02
Accepted
2024-04-02 16:01:34
Documents
15
Period of Report
2024-04-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d796750d8k.htm   iXBRL 8-K 29622
2 EX-3.1 d796750dex31.htm EX-3.1 36821
3 EX-3.2 d796750dex32.htm EX-3.2 174129
  Complete submission text file 0001193125-24-084736.txt   419033

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bold-20240402.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bold-20240402_lab.xml EX-101.LAB 19482
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bold-20240402_pre.xml EX-101.PRE 12171
18 EXTRACTED XBRL INSTANCE DOCUMENT d796750d8k_htm.xml XML 3977
Mailing Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SUITE 120 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Filer) CIK: 0001782303 (see all company filings)

IRS No.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 24814066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)